---
$id: https://graph.org.ai/products/commodity/51111776
$type: Product
source: UNSPSC
code: "51111776"
title: "Podofilox"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Podofilox

**UNSPSC Code**: 51111776
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a colchicine-site binding agent with the molecular formula C22H22O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L36H50F353, chemically known as furo(3,4:6,7)naphtho(2,3-d)-1,3-dioxol-6(5ah)-one, 5,8,8a,9-tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)- but more generally known as podofilox, which bears US NIH Compound Identifier 4865. European Medicines Agency schedules Podofilox in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14925MIG. World Health Organization schedules podofilox in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, PODOFILOX remains US FDA's Preferred Term for this commodity. Podofilox bears US NLM identifiers UMLS ID C0032334 and NCI Concept Code C29368. SMILES: O1CC2C(C(C3C(C2O)CC2OCOC2C3)C2CC(OC)C(OC)C(OC)C2)C1=O.

